Clinical trial

Amlexanox for Type 2 Diabetes and Obesity

NCT01842282

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2013-07-19

PhasePHASE2

Study timeline

Study start (actual)2013-07-19Date precision: day

Registry last updated2024-05-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus Type 2unresolved

Non Alcoholic Fatty Liver Diseaseunresolved

Obesityunresolved

Interventions

AmlexanoxDRUG · verified · RxNorm: amlexanox

Sponsors & collaborators

University of Michiganlead sponsor

Mapped research locations

Ann ArborMichigan, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01842282 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.